H. Lundbeck Dirección
Dirección controles de criterios 2/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Charl van Zyl
Chief Executive Officer (CEO)
DKK 39.6m
Compensación total
Porcentaje del salario del CEO | 6.8% |
Permanencia del CEO | less than a year |
Participación del CEO | n/a |
Permanencia media de la dirección | 2.1yrs |
Promedio de permanencia en la Junta Directiva | 3.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Do H. Lundbeck's (CPH:HLUN B) Earnings Warrant Your Attention?
Aug 22Investors Interested In H. Lundbeck A/S' (CPH:HLUN B) Earnings
Jul 01These 4 Measures Indicate That H. Lundbeck (CPH:HLUN B) Is Using Debt Safely
Jun 05H. Lundbeck (CPH:HLUN B) Will Pay A Larger Dividend Than Last Year At DKK0.70
Mar 07H. Lundbeck (CPH:HLUN B) Has Announced That It Will Be Increasing Its Dividend To DKK0.70
Feb 22H. Lundbeck A/S Just Missed Earnings - But Analysts Have Updated Their Models
Feb 10Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Jun 30 2024 | n/a | n/a | DKK 3b |
Mar 31 2024 | n/a | n/a | DKK 2b |
Dec 31 2023 | DKK 40m | DKK 3m | DKK 2b |
Compensación vs. Mercado: La compensación total de Charl($USD5.70M) está por encima de la media de empresas de tamaño similar en el mercado Danish ($USD2.72M).
Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Charl con los resultados de la empresa.
CEO
Charl van Zyl (57 yo)
less than a year
Permanencia
DKK 39,600,000
Compensación
Mr. Charl van Zyl served as Executive Vice President Neurology Solutions & Head of EU/International at UCB SA since February 2020 until June 2023. He serves as President and Chief Executive Officer of H. L...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
President & CEO | less than a year | DKK 39.60m | sin datos | |
CFO & Executive VP of Corporate Functions | 2.1yrs | DKK 10.90m | 0.0023% DKK 946.2k | |
Executive Vice President of Product Development & Supply | 5.7yrs | DKK 10.10m | 0.038% DKK 15.9m | |
Executive Vice President of Research & Development | 5.7yrs | DKK 11.30m | 0.014% DKK 5.8m | |
Senior VP & Head of Research | 3.3yrs | sin datos | sin datos | |
Chief Specialist & VP of Investor Relations | no data | sin datos | sin datos | |
Senior Vice President of Corporate Communications & Public Affairs | less than a year | sin datos | sin datos | |
Executive Vice President of People & Culture | less than a year | sin datos | sin datos | |
Senior Vice President of International Markets | no data | sin datos | sin datos | |
Senior VP & Head of Clinical Development | 2.7yrs | sin datos | sin datos | |
Senior Vice President of Group Finance | 2.1yrs | sin datos | sin datos | |
VP & Head of Experimental Medicine | no data | sin datos | sin datos |
2.1yrs
Permanencia media
58.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de HLUN B se considera experimentado (2 años antigüedad media).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Independent Chairman | 11.7yrs | DKK 1.70m | 0.010% DKK 4.2m | |
Deputy Chairman | 9.7yrs | DKK 1.20m | 0.0062% DKK 2.6m | |
Independent Director | 6.5yrs | DKK 1.20m | sin datos | |
Director | 9.7yrs | DKK 600.00k | 0.0076% DKK 3.2m | |
Director | 1.5yrs | DKK 450.00k | 0.0055% DKK 2.3m | |
Independent Director | 3.5yrs | DKK 70.00k | sin datos | |
Independent Director | 3.5yrs | DKK 1.00m | sin datos | |
Employee Representative Director | 2.5yrs | DKK 400.00k | 0.00010% DKK 41.7k | |
Employee Representative Director | 2.5yrs | DKK 400.00k | 0.00011% DKK 45.9k | |
Employee Representative Director | 2.5yrs | DKK 400.00k | sin datos | |
Employee Representative Director | 2.5yrs | DKK 400.00k | sin datos |
3.5yrs
Permanencia media
58yo
Promedio de edad
Junta con experiencia: La junta directiva de HLUN B se considera experimentada (3.3 años de antigüedad promedio).